Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

Multiple Ascending Dose Study

Key facts

Study ID

NCT00861718

Run by

AstraZeneca

People needed

40

Starts

2009-04-01

Expected to finish

2009-10-01

Last updated by the study team

2009-12-10

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of Informed Consent
• Healthy male subjects and female subjects (of non-child bearing potential)
• with suitable veins for cannulation or repeated venipuncture

You may not qualify if…

• Inability to understand or cooperate with given information
• Any positive result on screening for human immune deficiency virus (HIV), Hepatitis B, or Hepatitis C test
• History of seizure (including infancy febrile seizures) or family history of seizure

Where it is running

• Research Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.